Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1994 1
1995 3
1996 3
1997 2
1998 5
1999 22
2000 26
2001 33
2002 44
2003 57
2004 58
2005 101
2006 83
2007 115
2008 181
2009 208
2010 215
2011 186
2012 222
2013 203
2014 188
2015 157
2016 138
2017 125
2018 135
2019 133
2020 144
2021 149
2022 130
2023 118
2024 150
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,962 results

Results by year

Filters applied: . Clear all
Page 1
Effects of telmisartan on metabolic syndrome components: a comprehensive review.
Imenshahidi M, Roohbakhsh A, Hosseinzadeh H. Imenshahidi M, et al. Biomed Pharmacother. 2024 Feb;171:116169. doi: 10.1016/j.biopha.2024.116169. Epub 2024 Jan 15. Biomed Pharmacother. 2024. PMID: 38228033 Free article. Review.
Moreover, telmisartan has an agonist activity on PPARalpha and PPARdelta receptors and modulates the adipokine levels. ...This review will highlight the role of telmisartan in metabolic syndrome and the main mechanisms of action of telmisartan are discussed a …
Moreover, telmisartan has an agonist activity on PPARalpha and PPARdelta receptors and modulates the adipokine levels. ...This review …
Treatment of proteinuria in dogs with telmisartan: A retrospective study.
Lecavalier J, Fifle L, Javard R. Lecavalier J, et al. J Vet Intern Med. 2021 Jul;35(4):1810-1818. doi: 10.1111/jvim.16146. Epub 2021 May 10. J Vet Intern Med. 2021. PMID: 33969924 Free PMC article.
BACKGROUND: Use of telmisartan for the treatment of proteinuria in dogs has not been thoroughly investigated. HYPOTHESIS/OBJECTIVES: Telmisartan can be effective for the treatment of proteinuria in dogs. ANIMALS: Forty-four client-owned dogs with proteinuria. ...
BACKGROUND: Use of telmisartan for the treatment of proteinuria in dogs has not been thoroughly investigated. HYPOTHESIS/OBJECTIVES: …
Efficacy and safety of co-administered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemia.
Jin X, Kim MH, Han KH, Hong SJ, Ahn JC, Sung JH, Cho JM, Lee HC, Choi SY, Lee K, Kim WS, Rhee MY, Kim JH, Hong SP, Yoo BS, Cho EJ, Lee JH, Kim PJ, Park CG, Hyon MS, Shin JH, Lee SH, Sung KC, Hwang J, Kwon K, Chae IH, Seo JS, Kim H, Lee H, Cho Y, Kim HS. Jin X, et al. J Clin Hypertens (Greenwich). 2020 Oct;22(10):1835-1845. doi: 10.1111/jch.13893. Epub 2020 Sep 16. J Clin Hypertens (Greenwich). 2020. PMID: 32937023 Free PMC article. Clinical Trial.
We enrolled 202 patients who were randomly divided into the following three groups: telmisartan/amlodipine 80/5 mg + rosuvastatin 20 mg, telmisartan 80 mg + rosuvastatin 20 mg, and telmisartan/amlodipine 80/5 mg. The primary efficacy variables were changes fr …
We enrolled 202 patients who were randomly divided into the following three groups: telmisartan/amlodipine 80/5 mg + rosuvastatin 20 …
Efficacy and safety of standard dose triple combination of telmisartan 80 mg/amlodipine 5 mg/chlorthalidone 25 mg in primary hypertension: A randomized, double-blind, active-controlled, multicenter phase 3 trial.
Cho EJ, Kim MH, Kim YH, Chang K, Choi DJ, Kang WC, Shin J, Kim SH, Lee N, Son JW, Doh JH, Kim WS, Hong SJ, Rhee MY, Ahn Y, Lim SW, Hong SP, Choi SY, Hyon MS, Hwang JY, Kwon K, Cha KS, Ihm SH, Lee JH, Yoo BS, Kim HS. Cho EJ, et al. J Clin Hypertens (Greenwich). 2023 Sep;25(9):817-827. doi: 10.1111/jch.14707. Epub 2023 Aug 23. J Clin Hypertens (Greenwich). 2023. PMID: 37614053 Free PMC article. Clinical Trial.
The authors evaluated the efficacy, safety, and characteristics of patients who respond well to standard dose triple combination therapy including chlorthalidone 25 mg with telmisartan 80 mg plus amlodipine 5 mg in hypertensive patients. This is a multicenter, double-blind …
The authors evaluated the efficacy, safety, and characteristics of patients who respond well to standard dose triple combination therapy inc …
[Telmisartan in the treatment of hypertensive patients].
Podzolkov VI, Tarzimanova AI. Podzolkov VI, et al. Ter Arkh. 2017;89(6):110-113. doi: 10.17116/terarkh2017896110-113. Ter Arkh. 2017. PMID: 28745698 Review. Russian.
The paper highlights the use of telmisartan, one of the currently available angiotensin receptor blockers, for the treatment of patients with hypertension, metabolic syndrome, and those at high cardiovascular risk. Telmisartan treatment allows blood pressure control …
The paper highlights the use of telmisartan, one of the currently available angiotensin receptor blockers, for the treatment of patie …
Telmisartan inhibits microglia-induced neurotoxic A1 astrocyte conversion via PPARgamma-mediated NF-kappaB/p65 degradation.
Quan W, Xu CS, Li XC, Yang C, Lan T, Wang MY, Yu DH, Tang F, Wang ZF, Li ZQ. Quan W, et al. Int Immunopharmacol. 2023 Oct;123:110761. doi: 10.1016/j.intimp.2023.110761. Epub 2023 Aug 5. Int Immunopharmacol. 2023. PMID: 37544025 Free article.
A peroxisome proliferator-activated receptor gamma (PPARgamma) antagonist reversed the effects of telmisartan. Moreover, telmisartan-induced p65 downregulation was reversed by the proteasome inhibitor MG132. ...Our findings contribute towards the elucidation of the …
A peroxisome proliferator-activated receptor gamma (PPARgamma) antagonist reversed the effects of telmisartan. Moreover, telmisart …
Telmisartan: the ACE of ARBs?
Sharma AM. Sharma AM. Hypertension. 2006 May;47(5):822-3. doi: 10.1161/01.HYP.0000215184.00915.62. Epub 2006 Mar 27. Hypertension. 2006. PMID: 16567592 Review. No abstract available.
Fenofibrate and Telmisartan in the Management of Abdominal Aortic Aneurysm.
Rowbotham SE, Krishna SM, Moran CS, Golledge J. Rowbotham SE, et al. Curr Drug Targets. 2018;19(11):1241-1246. doi: 10.2174/1389450119666171227224655. Curr Drug Targets. 2018. PMID: 29284388 Review.
Telmisartan acts via blockade of the angiotensin II receptor, type 1, and also as a peroxisome proliferator-activated receptor gamma agonist. ...Based on these findings, there are currently three randomized controlled trials assessing both fenofibrate and telmisartan …
Telmisartan acts via blockade of the angiotensin II receptor, type 1, and also as a peroxisome proliferator-activated receptor gamma …
Telmisartan Alleviates Alzheimer's Disease-Related Neuropathologies and Cognitive Impairments.
Fu XX, Wei B, Cao HM, Duan R, Deng Y, Lian HW, Zhang YD, Jiang T. Fu XX, et al. J Alzheimers Dis. 2023;94(3):919-933. doi: 10.3233/JAD-230133. J Alzheimers Dis. 2023. PMID: 37355897
There are few effective medications for halting the progression of AD. Telmisartan (TEL) is a widely used anti-hypertensive drug approved by FDA. Aside from treating hypertension, TEL has been revealed to provide protection against AD. ...
There are few effective medications for halting the progression of AD. Telmisartan (TEL) is a widely used anti-hypertensive drug appr …
Efficacy and safety of combination therapy with telmisartan, rosuvastatin, and ezetimibe in patients with dyslipidemia and hypertension: A randomized, double-blind, multicenter, therapeutic confirmatory, phase III clinical trial.
Lee CJ, Kang WC, Ihm SH, Sohn IS, Woo JS, Kim JW, Hong SJ, Choi JH, Suh JW, Seo JB, Doh JH, Son JW, Park JH, Lee JH, Hong YJ, Heo JH, Shin J, Kang SM. Lee CJ, et al. J Clin Hypertens (Greenwich). 2024 Mar;26(3):262-273. doi: 10.1111/jch.14778. Epub 2024 Feb 6. J Clin Hypertens (Greenwich). 2024. PMID: 38319595 Free PMC article. Clinical Trial.
This study aimed to compare and evaluate the efficacy of the blood pressure (BP) control and cholesterol-lowering effects and safety of combination therapy with telmisartan, rosuvastatin, and ezetimibe versus rosuvastatin and ezetimibe double therapy or telmisartan …
This study aimed to compare and evaluate the efficacy of the blood pressure (BP) control and cholesterol-lowering effects and safety of comb …
2,962 results